Company overview
LifeArc provides intellectual property management, technology development, early-stage drug discovery, antibody humanization, and diagnostics development services to academic, biotech, and pharmaceutical organizations. It offers funding, partnerships, and commercialization support to translate research into therapies, with successes including pembrolizumab and lecanemab. Profits are reinvested into further medical research focused on rare diseases and global health challenges.
LifeArc is listed in the NovaPharmaNews Supplier Hub as a Life Science Reagents, Diagnostics & Testing partner serving United States & Americas. Core focus areas include lifearc, drug discovery services, antibody humanization, diagnostics development, pharma partnerships, rare disease research.
Industry categories: Life Science Reagents, Diagnostics & Testing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with LifeArc include Diagnostic — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://www.lifearc.org
- Categories
- Life Science Reagents, Diagnostics & Testing
- Markets served
- United States & Americas
- Keywords
- lifearc, drug discovery services, antibody humanization, diagnostics development, pharma partnerships, rare disease research
Products & technologies
Therapeutic areas
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What services does LifeArc offer for drug discovery and development?
- LifeArc offers early-stage drug discovery, antibody humanization, technology development, and commercialization services, including IP identification, protection, and licensing for academic, biotech, and pharma partners.
- Does LifeArc support diagnostics development?
- Yes, LifeArc provides full diagnostics development from assay design and verification to clinical validation, focusing on early detection, disease progression, companion diagnostics, and novel biomarkers aligned with specific health challenges.
- What are LifeArc's therapeutic focus areas and funding options?
- LifeArc targets rare diseases, global health challenges like TB, motor neuron disease, and childhood cancers, offering funding through open calls, investments via LifeArc Ventures, and partnerships for gene therapy and translational research.
Related editorial coverage
- BioMed Israel: Daily Highlights and Key Takeaways
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
Explore lab tools and QA/QC resources for R&D teams.
